Daily Journal Staff Writer
The U.S. attorney's office in San Francisco announced Thursday that the pharmaceutical company Mallinckrodt plc will pay $3.5 million to settle fraud claims. Prosecutors alleged the Irish company paid doctors to encourage them to prescribe company medications, which led to the filing of false Medicare and Medicaid claims between 2005 and 2010.
"This settlement demonstrates this office's c...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In